Hengrui raises HKD9.8bn in HK’s largest pharma IPO in 5 years
Jiangsu Hengrui Pharmaceuticals debuted on the Hong Kong Stock Exchange today, raising HKD9.89 billion (USD1.26 billion), marking the largest healthcare IPO in Hong Kong in nearly five years. Cleary Gottlieb, Commerce & Finance Law Offices, Pillsbury, …